Corporate Score 25 Neutral

Matinas BioPharma receives notice from NYSE

Apr 03, 2026 21:20 UTC

MATN

Short term

Matinas BioPharma receives notice from NYSE.

Share this article

Impact

Sentiment

Neutral

Type

Corporate

Horizon

Short

Risk Level

Low

AI will analyze the impact on affected symbols and provide trading insights

Get AI-powered insights, advanced filtering, real-time alerts, and unlimited analysis.

Apr 07, 00:47

Apr 07, 00:33

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.